This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Aldo Vincent Londino, Jr, MD; Gary L. Wolf, MD; John J. Calabro, MD; Samuel J. Perrone, MD
St Vincent Hospital Worcester, Mass

JAMA. 1984;252(14):1853.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The relationship between the use of drugs and pulmonary disease is being recognized with greater frequency. Approximately 5% of patients admitted to hospitals are there because of adverse reactions to drugs.¹ With reference to the article "Pulmonary Infiltrates Associated With Naproxen,"² the following case is reported in support of a hypersensitivity pneumonitis due to naproxen sodium.

Report of a Case.—

A 48-year-old woman had seropositive rheumatoid arthritis and a biopsy-proved diagnosis of "rheumatoid lung" seven years ago. She had right and left upper lobe pulmonary infiltrates, with prompt and complete resolution following therapy with prednisone, 60 mg daily.

Three years later she had pulmonary infiltrates while receiving naproxen sodium, 250 mg twice a day; a sputum examination at that time revealed clumps of eosinophils with a peripheral eosinophil count of 1,104/cu mm. Again, there was complete resolution following prednisone therapy. In February 1984, she was . . . [Full Text PDF of this Article]

Footnotes
Edited by John D. Archer, MD, Senior Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?